Novel conformationally constrained analogues of diacylglycerol. Protein kinase C binding affinity of simplified compounds based on a 6-membered lactam moiety

Bioorganic & Medicinal Chemistry Letters
1997.0

Abstract

Four configurational isomers of 6-hydroxymethyl-3-isopropyl-4-tetradecylpiperazin-2-ones (4-7), which were designed based on information obtained from the biologically active conformation of teleocidins and benzolactams, were synthesized and evaluated for their ability to compete with [3H]phorbol 12,13-dibutyrate in a PKC8 binding assay. Among the compounds, the 3S,6S-isomer (5) showed moderate binding affinity, 8-30 fold more potent than for the other isomers. This indicates that the relative position of the hydrogen-bonding sites and hydrophobic regions of 5 fits into the cavity of PKC5 binding site. Compound 5 provides a conformationally constrained analogue of diacylglycerol. © 1997 Elsevier Science Ltd.

Knowledge Graph

Similar Paper

Novel conformationally constrained analogues of diacylglycerol. Protein kinase C binding affinity of simplified compounds based on a 6-membered lactam moiety
Bioorganic & Medicinal Chemistry Letters 1997.0
Synthesis, Conformational Analysis, and Biological Evaluation of 1-Hexylindolactam-V10 as a Selective Activator for Novel Protein Kinase C Isozymes
Journal of Medicinal Chemistry 2008.0
Clarification of the Binding Mode of Teleocidin and Benzolactams to the Cys2 Domain of Protein Kinase Cδ by Synthesis of Hydrophobically Modified, Teleocidin-Mimicking Benzolactams and Computational Docking Simulation
Journal of Medicinal Chemistry 1998.0
The amide hydrogen of (−)-indolactam-V and benzolactam-V8’s plays a critical role in protein kinase c binding and tumor-promoting activities
Bioorganic & Medicinal Chemistry Letters 2001.0
Synthesis and PKC isozyme surrogate binding of indothiolactam-V, a new thioamide analogue of tumor promoting indolactam-V
Bioorganic & Medicinal Chemistry Letters 2000.0
Synthesis and protein kinase C binding activity of benzolactam-V7
Bioorganic & Medicinal Chemistry Letters 1999.0
Modeling, Chemistry, and Biology of the Benzolactam Analogues of Indolactam V (ILV). 2. Identification of the Binding Site of the Benzolactams in the CRD2 Activator-Binding Domain of PKCδ and Discovery of an ILV Analogue of Improved Isozyme Selectivity
Journal of Medicinal Chemistry 1997.0
Probing the Binding of Indolactam-V to Protein Kinase C through Site-Directed Mutagenesis and Computational Docking Simulations
Journal of Medicinal Chemistry 1999.0
Synthesis of structural analogs of lyngbyatoxin A and their evaluation as activators of protein kinase C
Journal of Medicinal Chemistry 1991.0
(S)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1H,13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-dione (LY333531) and Related Analogues:  Isozyme Selective Inhibitors of Protein Kinase Cβ
Journal of Medicinal Chemistry 1996.0